EMEA recommends approval of Sanofi-aventis' dronedarone for atrial fibrillation
Tuesday, September 29, 2009 10:00 IST Paris, France
Sanofi-aventis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization